Zhitong Finance App News, Zhongheng Group (600252.SH) announced that Zhongheng Yixinke Venture Capital Co., Ltd. (Zhongheng Yixin), a wholly-owned subsidiary of the company, intends to transfer 34% of its shares in Fosun Pharmaceutical (Nanning) Co., Ltd. (Fosun Nanning for short) through public listing. The listing price is not less than 11.1373 million yuan. The final transaction amount and counterparty are subject to the public listing transaction results. After the share transfer is completed, Zhongheng Yixin will no longer hold shares in Fosun Nanning.

After the listing and sale is completed, it will help optimize the company's resource allocation and maximize asset value.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.